Search results
Results From The WOW.Com Content Network
Bayer AG ( English: / ˈbaɪ.ər /, commonly pronounced / ˈbeɪər /; [3] German: [ˈbaɪɐ]) is a German multinational pharmaceutical and biotechnology company and is one of the largest pharmaceutical companies and biomedical companies in the world. Headquartered in Leverkusen, Bayer's areas of business include: pharmaceuticals, consumer ...
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. [2] The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions. The company had 2017 sales of $10.6 billion, across two businesses: BioScience and Medical Products.
Bayer Corporation (also known as Bayer USA) is the American subsidiary of Bayer AG. Its main offices are located in Whippany, New Jersey . In addition it has 40 fully consolidated subsidiary companies [3] located in 19 different states.
Bayer's CEO Bill Anderson is reinventing the 160-year-old company for the 21st century. ... Bayer’s DSO may become a model for others looking to reinvent the corporation for the 21st century ...
C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one. Headquartered in Ingelheim, it operates ...
A top Bayer pharmaceutical executive said on Wednesday his group will continue slashing managerial jobs this year, planning cuts in Germany, Japan, the United Kingdom, Belgium and the Netherlands ...
According to Buhler, a small medical company—later identified by Buhler as a precursor to pharmaceutical giant Bayer—reached out to the Third Reich during World War II asking for 150 ...
Bayer. Roche. Genentech. Children. 3. William Anderson (born August 23, 1966) is an American business executive who has been the chief executive officer (CEO) of Bayer AG since June 2023. [1] [2] Prior to his current role, Anderson was CEO of Genentech from 2017 to 2018, and later CEO of the Roche 's Pharmaceuticals Division from 2019 to 2022.